These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19082471)

  • 1. ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer.
    Bessho Y; Oguri T; Ozasa H; Uemura T; Sakamoto H; Miyazaki M; Maeno K; Sato S; Ueda R
    Oncol Rep; 2009 Jan; 21(1):263-8. PubMed ID: 19082471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer.
    Oguri T; Ozasa H; Uemura T; Bessho Y; Miyazaki M; Maeno K; Maeda H; Sato S; Ueda R
    Mol Cancer Ther; 2008 May; 7(5):1150-5. PubMed ID: 18445659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistance.
    Zhou Y; Hopper-Borge E; Shen T; Huang XC; Shi Z; Kuang YH; Furukawa T; Akiyama S; Peng XX; Ashby CR; Chen X; Kruh GD; Chen ZS
    Biochem Pharmacol; 2009 Mar; 77(6):993-1001. PubMed ID: 19150344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel.
    Hopper-Borge E; Chen ZS; Shchaveleva I; Belinsky MG; Kruh GD
    Cancer Res; 2004 Jul; 64(14):4927-30. PubMed ID: 15256465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in the ATP binding cassette transporter ABCC10 is associated with neutropenia for docetaxel in Japanese lung cancer patients cohort.
    Sone K; Oguri T; Uemura T; Takeuchi A; Fukuda S; Takakuwa O; Maeno K; Fukumitsu K; Kanemitsu Y; Ohkubo H; Takemura M; Ito Y; Niimi A
    BMC Cancer; 2019 Mar; 19(1):246. PubMed ID: 30890141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of multidrug resistance-associated protein gene in non-small cell lung cancer].
    Xu M; Li J; Xia Q
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):268-70. PubMed ID: 11775850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance-associated protein 7 expression is involved in cross-resistance to docetaxel in salivary gland adenocarcinoma cell lines.
    Naramoto H; Uematsu T; Uchihashi T; Doto R; Matsuura T; Usui Y; Uematsu S; Li X; Takahashi M; Yamaoka M; Furusawa K
    Int J Oncol; 2007 Feb; 30(2):393-401. PubMed ID: 17203221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor efficacy of oblimersen Bcl-2 antisense oligonucleotide alone and in combination with vinorelbine in xenograft models of human non-small cell lung cancer.
    Hu Y; Bebb G; Tan S; Ng R; Yan H; Sartor JR; Mayer LD; Bally MB
    Clin Cancer Res; 2004 Nov; 10(22):7662-70. PubMed ID: 15569999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ABCG2 as a biomarker for predicting resistance to CPT-11/SN-38 in lung cancer.
    Bessho Y; Oguri T; Achiwa H; Muramatsu H; Maeda H; Niimi T; Sato S; Ueda R
    Cancer Sci; 2006 Mar; 97(3):192-8. PubMed ID: 16542215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines.
    Huang R; Murry DJ; Kolwankar D; Hall SD; Foster DR
    Biochem Pharmacol; 2006 Jun; 71(12):1695-704. PubMed ID: 16620787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines.
    Chiu LY; Ko JL; Lee YJ; Yang TY; Tee YT; Sheu GT
    Toxicol Lett; 2010 Feb; 192(3):408-18. PubMed ID: 19944135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDR1 single nucleotide polymorphisms predict response to vinorelbine-based chemotherapy in patients with non-small cell lung cancer.
    Pan JH; Han JX; Wu JM; Sheng LJ; Huang HN; Yu QZ
    Respiration; 2008; 75(4):380-5. PubMed ID: 17851225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ABCC10/MRP7 in anti-cancer drug resistance and beyond.
    Chen DQ; Xie Y; Cao LQ; Fleishman JS; Chen Y; Wu T; Yang DH
    Drug Resist Updat; 2024 Mar; 73():101062. PubMed ID: 38330827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10).
    Shen T; Kuang YH; Ashby CR; Lei Y; Chen A; Zhou Y; Chen X; Tiwari AK; Hopper-Borge E; Ouyang J; Chen ZS
    PLoS One; 2009 Oct; 4(10):e7520. PubMed ID: 19841739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combretastatin A-4 resistance in H460 human lung carcinoma demonstrates distinctive alterations in beta-tubulin isotype expression.
    Wehbe H; Kearney CM; Pinney KG
    Anticancer Res; 2005; 25(6B):3865-70. PubMed ID: 16309172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors.
    Zhang H; Patel A; Wang YJ; Zhang YK; Kathawala RJ; Qiu LH; Patel BA; Huang LH; Shukla S; Yang DH; Ambudkar SV; Fu LW; Chen ZS
    Mol Cancer Ther; 2017 Jun; 16(6):1021-1030. PubMed ID: 28265007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B.
    Hopper-Borge E; Xu X; Shen T; Shi Z; Chen ZS; Kruh GD
    Cancer Res; 2009 Jan; 69(1):178-84. PubMed ID: 19118001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of multi-drug resistance associated proteins MRP1 (ABCC1) and MRP3 (ABCC3) from rainbow trout (Oncorhynchus mykiss).
    Fischer S; Pietsch M; Schirmer K; Luckenbach T
    Mar Environ Res; 2010; 69 Suppl():S7-S10. PubMed ID: 19963264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer.
    Gan PP; Pasquier E; Kavallaris M
    Cancer Res; 2007 Oct; 67(19):9356-63. PubMed ID: 17909044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. bba, a synthetic derivative of 23-hydroxybutulinic acid, reverses multidrug resistance by inhibiting the efflux activity of MRP7 (ABCC10).
    Chen JJ; Patel A; Sodani K; Xiao ZJ; Tiwari AK; Zhang DM; Li YJ; Yang DH; Ye WC; Chen SD; Chen ZS
    PLoS One; 2013; 8(9):e74573. PubMed ID: 24069321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.